Harrington Rare Disease Scholar Award Program sponsored by Takeda

Funding Agency:
University Hospitals Harrington Discovery Institute

The Harrington Rare Disease Scholar Award was created to advance breakthrough research into novel treatments for rare diseases. The Harrington Rare Disease Scholar Program is sponsored by Takeda Pharmaceutical Company Limited and overseen by Harrington Discovery Institute. 

The Harrington Rare Disease Scholar Program will provide funding and hands-on drug development guidance for two years to U.S.-based MD and PhD researchers whose discoveries show promise for translation into novel medicines for rare diseases.


  • Required Letter of Intent: July 19, 2017
  • Full Application: October 4, 2017

Agency Website

Areas of Interest

Our current target areas of interest include all rare diseases, but of particular interest are rare diseases in the areas of neurology and gastroenterology. Projects in the area of rare cancers will be considered on a case-by-case basis. 

Eligibility Requirements

• Academic investigators on faculty at accredited medical centers, research institutions, and universities in the United States only • Lead investigator must have an MD and/or PhD (or equivalent) • Past recipients of Harrington Scholar awards may submit new and distinct proposals, but may not seek additional support for previously funded projects



Amount Description

$150,000 guaranteed; potential award of up to $1,000,000 

Funding Type



Junior Faculty


Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

July 19, 2017